This brand name is authorized in France, Tunisia
The drug TARDYFERON B9 contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Folic acid
UNII 935E97BOY8 - FOLIC ACID
|
|
Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues. |
|
2
Ferrous sulfate
UNII 39R4TAN1VT - FERROUS SULFATE
|
|
Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AD03 | Ferrous sulfate and folic acid | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AD Iron in combination with folic acid |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 64875192 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9323023, 9323026 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
